Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2431–2445 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4235 SPR Gene Dystonia (DOPA‑Responsive, Autosomal Recessive) Genetic Test (NGS) This test identifies pathogenic variants in the SPR gene associated with DOPA-responsive dystonia, an autosomal recessive disorder.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPR gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory before sampling"] Indications ["Suspected DOPA-responsive dystonia", "Family history of DOPA-responsive dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 94309-9 ICD-10: G24.8, Z14.8, Z36.89 Clinical summary This test identifies pathogenic variants in the SPR gene associated with DOPA-responsive dystonia, an autosomal recessive disorder.
TEST-4844 SPRED1 Gene Legius Syndrome Genetic Test This test evaluates the SPRED1 gene for pathogenic variants associated with Legius syndrome.	Whole Blood (Peripheral)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SPRED1 gene sequence", "Copy number variants in SPRED1"] Parameters [] Preparation ["No dietary or fasting preparation required", "Inform phlebotomist of current medications, supplements, or bleeding disorders"] Indications ["Clinical suspicion of Legius syndrome", "Differentiation from Neurofibromatosis Type 1 (NF1)"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q85.09 Clinical summary This test evaluates the SPRED1 gene for pathogenic variants associated with Legius syndrome.
TEST-4338 SPTAN1 Gene Early Infantile Epileptic Encephalopathy Type 5 Genetic Test This genetic test evaluates the SPTAN1 gene for pathogenic variants associated with Early Infantile Epileptic Encephalopathy Type 5 (EIEE5).	Peripheral Whole Blood (EDTA) or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTAN1 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Early Infantile Epileptic Encephalopathy Type 5 (EIEE5)", "Relevant family history"] Measurement technique Confirm with laboratory Codes LOINC: 80772-9 ICD-10: G40.4 Clinical summary This genetic test evaluates the SPTAN1 gene for pathogenic variants associated with Early Infantile Epileptic Encephalopathy Type 5 (EIEE5).
TEST-3364 SPTB Gene Sequencing for Neonatal Hemolytic Anemia (Fatal/Near‑Fatal) NGS Test This test identifies pathogenic variants in the SPTB gene associated with hereditary spherocytosis, a cause of severe neonatal hemolytic anemia.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTB gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["Mandatory Pre-Test Genetic Counselling"] Indications ["Neonates presenting with unexplained hemolytic anemia", "Suspected hereditary spherocytosis", "Family history of hereditary spherocytosis"] Measurement technique Confirm with laboratory Codes LOINC: 79047-4 ICD-10: D58.0 Clinical summary This test identifies pathogenic variants in the SPTB gene associated with hereditary spherocytosis, a cause of severe neonatal hemolytic anemia.
TEST-3168 SPTB Gene Spherocytosis Type 2 Genetic Test This test identifies pathogenic mutations within the SPTB gene associated with Hereditary Spherocytosis Type 2.	Peripheral Whole Blood, FTA Card, or Isolated Genomic DNA	3 to 4 Weeks (19–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTB gene", "Copy Number Variants (CNVs) in the SPTB gene"] Parameters [] Preparation ["Requires documented pre-test genetic counseling session", "Written informed consent and completed clinical history form including a three-generation pedigree are required"] Indications ["Suspected Hereditary Spherocytosis Type 2", "Family history of Hereditary Spherocytosis", "Need for precise diagnosis to guide treatment", "Cascade screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 81316-6 ICD-10: D58.0 Clinical summary This test identifies pathogenic mutations within the SPTB gene associated with Hereditary Spherocytosis Type 2.
TEST-5798 SPTBN2 Gene Sequencing (Spinocerebellar Ataxia Type 5, Autosomal Dominant) Test This test identifies pathogenic variants in the SPTBN2 gene to diagnose autosomal dominant spinocerebellar ataxia type 5 (SCA5).	Peripheral Whole Blood (3–5 mL in EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTBN2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected hereditary ataxia", "Family history of SCA5", "Need for definitive diagnosis of SCA5"] Measurement technique Confirm with laboratory Codes LOINC: 94547-4 ICD-10: G11.2 Clinical summary This test identifies pathogenic variants in the SPTBN2 gene to diagnose autosomal dominant spinocerebellar ataxia type 5 (SCA5).
TEST-5449 SPTBN5 Gene Neuronal Migration Disorder Genetic Test This genetic test evaluates the SPTBN5 gene for sequence variants and small deletions/duplications linked to neuronal migration disorders.	Peripheral whole blood (3–5 mL in EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SPTBN5 gene sequence variants", "Small deletions/duplications in SPTBN5 gene"] Parameters [] Preparation [] Indications ["Suspected SPTBN5-associated neuronal migration disorder", "Complex neurological presentations"] Measurement technique Confirm with laboratory Codes LOINC: 21523-3 ICD-10: Q04.8 Clinical summary This genetic test evaluates the SPTBN5 gene for sequence variants and small deletions/duplications linked to neuronal migration disorders.
TEST-4498 SPTLC1 Gene HSAN1 Genetic Test This genetic test detects pathogenic variants in the SPTLC1 gene to confirm a diagnosis of hereditary sensory and autonomic neuropathy type 1 (HSAN1).	Peripheral whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTLC1 gene", "Genetic predisposition to HSAN1"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected hereditary sensory and autonomic neuropathy type 1 (HSAN1)", "Family history of HSAN1", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94216-8 ICD-10: G60.8 Clinical summary This genetic test detects pathogenic variants in the SPTLC1 gene to confirm a diagnosis of hereditary sensory and autonomic neuropathy type 1 (HSAN1).
TEST-5373 SPTLC2 Gene Neuropathy, Hereditary Sensory and Autonomic Type 1C (HSAN1C) Genetic Test This test identifies pathogenic variants in the SPTLC2 gene, confirming a diagnosis of Hereditary Sensory and Autonomic Neuropathy Type 1C (HSAN1C).	Whole Blood (EDTA tube), Extracted DNA (minimum 1 µg), or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTLC2 gene", "Serine palmitoyltransferase enzyme function"] Parameters [] Preparation ["No fasting required for whole blood collection", "Inform phlebotomist if on anticoagulant therapy"] Indications ["Clinical suspicion of HSAN1C", "Patients with progressive sensory neurodegeneration", "Patients with autonomic dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 101621-2 ICD-10: G60.8 Clinical summary This test identifies pathogenic variants in the SPTLC2 gene, confirming a diagnosis of Hereditary Sensory and Autonomic Neuropathy Type 1C (HSAN1C).
TEST-4673 SQSTM1 Gene Paget Disease of Bone Genetic Test This test evaluates the SQSTM1 gene for pathogenic variants associated with Paget disease of bone and related disorders.	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SQSTM1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation [] Indications ["Adults with early-onset bone deformities", "Adults with unexplained fractures", "Adults with a family history of Paget disease"] Measurement technique Confirm with laboratory Codes LOINC: 92878-1 ICD-10: M88.9 Clinical summary This test evaluates the SQSTM1 gene for pathogenic variants associated with Paget disease of bone and related disorders.
TEST-5069 SRCAP Gene Floating-Harbor Syndrome Genetic Test This test identifies pathogenic variants within the SRCAP gene associated with Floating-Harbor syndrome.	Whole Blood, Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SRCAP gene", "Copy Number Variations (CNVs) in the SRCAP gene"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Suspected Floating-Harbor syndrome", "Syndromic short stature"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants within the SRCAP gene associated with Floating-Harbor syndrome.
TEST-6178 SRD5A3 Gene Congenital Disorder of Glycosylation, Type Iq Genetic Test This genetic test analyzes the SRD5A3 gene to detect pathogenic variants associated with Congenital Disorder of Glycosylation Type Iq.	Whole Blood (EDTA), Extracted DNA, or One Drop of Blood on FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SRD5A3 gene"] Parameters [] Preparation ["Fasting is not necessary", "Share clinical history and prior reports", "Mandatory Genetic Counselling session required before sample collection"] Indications ["Suspected Congenital Disorder of Glycosylation Type Iq", "Family history of CDG-Iq"] Measurement technique Confirm with laboratory Codes LOINC: 61738-5 ICD-10: E77.8 Clinical summary This genetic test analyzes the SRD5A3 gene to detect pathogenic variants associated with Congenital Disorder of Glycosylation Type Iq.
TEST-1891 SRGAP1 Gene Mutation Analysis for Hereditary Nonmedullary Thyroid Cancer (Type 2) Test This genetic test identifies mutations in the SRGAP1 gene linked to hereditary nonmedullary thyroid cancer type 2.	Peripheral blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SRGAP1 gene mutations", "Hereditary susceptibility to nonmedullary thyroid cancer type 2"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Individuals with a family history of nonmedullary thyroid cancer", "Personal history suggestive of hereditary cancer syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z15.09 Clinical summary This genetic test identifies mutations in the SRGAP1 gene linked to hereditary nonmedullary thyroid cancer type 2.
TEST-5566 SRPX2 Gene DNA Test for Rolandic Epilepsy, Intellectual Disability & Speech Dyspraxia This test identifies pathogenic variants in the SRPX2 gene associated with Rolandic epilepsy, intellectual disability, and speech dyspraxia.	Peripheral Whole Blood, Dried Blood Spot (DBS), or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SRPX2 gene", "Coding region and splice site variants"] Parameters [] Preparation ["No special preparation is needed.", "Pre-test genetic counselling session is strongly recommended.", "Do not discontinue antiepileptic medications without consulting your treating neurologist."] Indications ["Diagnosis of SRPX2-related disorders", "Familial risk assessment", "Personalized management guidance"] Measurement technique Confirm with laboratory Codes LOINC: 51955-5 ICD-10: Z13.71, G40.0, F70, R48.2 Clinical summary This test identifies pathogenic variants in the SRPX2 gene associated with Rolandic epilepsy, intellectual disability, and speech dyspraxia.
TEST-3476 SRY Gene 46,XX Sex Reversal Type 1 (NGS) Test This diagnostic test evaluates for pathogenic variants within the SRY gene, which are the primary cause of 46,XX sex reversal type 1.	Peripheral Whole Blood (EDTA) or Buccal Swab	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in SRY gene (SNVs, Indels, CNVs)", "SRY gene copy number variations"] Parameters [] Preparation [] Indications ["Diagnosis of 46,XX testicular disorder of sex development (DSD)", "Confirmation of 46,XX sex reversal type 1"] Measurement technique Confirm with laboratory Codes LOINC: 21642-1 ICD-10: Q98.3 Clinical summary This diagnostic test evaluates for pathogenic variants within the SRY gene, which are the primary cause of 46,XX sex reversal type 1.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories